T cells engineered with T-cell antigen coupler (TAC) receptors display robust efficacy against solid and liquid tumor xenografts in the absence of any toxicity Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Helsen, CW
  • Hammill, J
  • Mwawasi, K
  • Lau, V
  • Hayes, D
  • Afsahi, A
  • Bezverbnaya, K
  • Newhook, L
  • Aarts, C
  • Denisova, G
  • Bramson, Jonathan

publication date

  • May 2018